Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare | Johannesburg | Healthcare | Pharmaceuticals | R 52.62B | 11.8x | -1.47 | ZAC 11,846 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | R 19.93B | -21.4x | 0.16 | ZAC 1,382 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | R 17.93B | 12.1x | 0.49 | ZAC 1,471 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | R 17.81B | 12.1x | ZAC 8,853 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Adcock Ingram | Johannesburg | Healthcare | Pharmaceuticals | R 7.36B | 9.6x | -1.09 | ZAC 5,013 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | R 550.66M | 29x | 0.2 | ZAC 88 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numeral | Johannesburg | Healthcare | Biotechnology & Medical Research | R 247.44M | ZAC 1 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | R 209.50M | 253.5x | ZAC 295 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |